Company / Gross Margin
Tandem Diabetes Care Gross Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Gross Margin
53.8%
FY2025
5-year range
49.2% / 53.8%
FY2021-FY2025
Trend
+3.3%
vs FY2024
Sector context
#56 of 96
Health Care
What the data says
At 53.8%, Tandem Diabetes Care's gross margin ranks #56 of 96 in the Health Care sector. Gross Margin has fluctuated over the past 10 years, ranging from 28.0% in FY2018 to 53.8% in FY2025.
Based on SEC 10-K filings.
53.8% in FY2025 with a 5-year CAGR of +5.0%.
Improved from 49.2% to 53.8% over the past 2 years.
Health Care sector context is included.
Gross Margin over time
Growth rates
- 3-Year Change
- +1.6pp
- 5-Year Change
- +5.0pp
- 10-Year Change
- -
Sector benchmark
In line with sector averageTop 58% of 96This company 53.8% Sector average 53.6%
▼
In line with sector average
Key checks
Key Insights
- In FY2025, gross margin increased 3.3% year-over-year.
- Currently 0.2pp above the Health Care sector average.
- Lowest gross margin in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -0.32 (distress zone, below 1.8 threshold)
- Negative profit margin: -20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Gross MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 53.8% | +3.3% |
| FY2024 | 52.1% | +5.9% |
| FY2023 | 49.2% | -5.9% |
| FY2022 | 52.2% | -2.6% |
| FY2021 | 53.6% | +9.7% |
| FY2020 | 48.9% | +19.2% |
| FY2019 | 41.0% | +46.4% |
| FY2018 | 28.0% | -23.3% |
| FY2017 | 36.5% | +30.3% |
| FY2016 | 28.0% | -23.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026